Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics

In Vitro Diagnostics

FDA approves Banyan Biomarkers’ diagnostic blood test for traumatic brain injury By MDBR Staff Writer
Banyan Biomarkers has secured marketing approval from the US Food and Drug Administration (FDA) for the first in vitro diagnostic blood test for traumatic brain injury (TBI).
Diagnostics > In Vitro Diagnostics > News
Anitoa launches ultra-portable qPCR system Anitoa Systems has introduced Maverick, an ultra-portable quantitative-polymerase-chain-reaction (qPCR) system.
Diagnostics > In Vitro Diagnostics > News Qiagen gets Japanese approval for QuantiFERON-TB Gold Plus in vitro diagnostic test Qiagen has secured approval from the Japan’s Ministry of Health Labor and Welfare for QuantiFERON-TB Gold Plus (QFT-Plus) as an in vitro diagnostic to detect tuberculosis (TB) infection.
Diagnostics > In Vitro Diagnostics > News
See more In Vitro Diagnostics news

Latest In Vitro Diagnostics News and Insight

View all In Vitro Diagnostics news or find news targeted to your interests
Anitoa launches ultra-portable qPCR system
Anitoa Systems has introduced Maverick, an ultra-portable quantitative-polymerase-chain-reaction (qPCR) system.
Diagnostics > In Vitro Diagnostics > News
Qiagen gets Japanese approval for QuantiFERON-TB Gold Plus in vitro diagnostic test
Qiagen has secured approval from the Japan’s Ministry of Health Labor and Welfare for QuantiFERON-TB Gold Plus (QFT-Plus) as an in vitro diagnostic to detect tuberculosis (TB) infection.
Diagnostics > In Vitro Diagnostics > News
Abbott supports Angle's breast cancer liquid biopsy study
By MDBR Staff Writer
Healthcare firm Abbott will provide its PathVysion HER-2 DNA FISH probe kits for use in Angle's breast cancer liquid biopsy study.
Diagnostics > In Vitro Diagnostics > News
Siemens Healthineers gets FDA clearance for blood urea nitrogen and total C02 point-of-care testing
Siemens Healthineers announced has received 510(k) clearance from the US Food and Drug Administration for its blood urea nitrogen (BUN) and total carbon dioxide (TCO2) point-of-care tests to aid in the diagnosis of renal diseases and metabolic imbalances.
Diagnostics > In Vitro Diagnostics > News
Pfizer, Foundation Medicine to develop companion diagnostics for oncology treatments
By MDBR Staff Writer
Pfizer has collaborated with Foundation Medicine for the development of companion diagnostics (CDx) for its oncology portfolio.
Diagnostics > In Vitro Diagnostics > News
GE, Roche partner to develop clinical decision support software
GE Healthcare and Roche have partnered to develop integrated digital diagnostics platform to enhance oncology and critical care treatment.
Diagnostics > In Vitro Diagnostics > News
View all In Vitro Diagnostics news or find news targeted to your interests